{
  "id": "SCR-LIP-000677",
  "statement": "Functional impairment in lipedema appears to worsen with advancing stage and lipolymphedema, though quantitative data are limited.",
  "claim_type": "clinical_association",
  "context": {
    "population": "US women with lipedema undergoing reduction surgery",
    "condition": "lipedema",
    "exposure": "advanced stage lipedema or lipo-lymphedema",
    "comparator": "earlier-stage lipedema",
    "outcome": "functional disability (LEFS score) and mobility improvement",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.1097/gox.0000000000003553",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2021,
      "amato_authored": false,
      "note": "This self-reported survey documents the existence of lipo-lymphedema as an advanced presentation and its association with worse functional (LEFS) scores and mobility impairment, providing contextual evidence that lipedema can co-occur with ",
      "title": "Survey Outcomes of Lipedema Reduction Surgery in the United States",
      "authors": "Herbst et al.",
      "journal": "Plastic and Reconstructive Surgery - Global Open",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "stance adopted from independent verifier (context→supporting). The source directly confirms both the inverse correlation between stage/lipo-lymphedema and LEFS score (r²=0.11, P=0.0001) and the mobility improvement percentages (stage 3: 96%",
        "date": "2026-06-10"
      },
      "quote": "Correlação inversa significativa entre estágio/lipo-linfedema e escore LEFS (r²=0,11; P=0,0001); Stage 1/2 com LEFS significativamente maior que lipo-linfedema",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "In US women having reduction surgery, stage/lipo-lymphedema correlated inversely with LEFS score (r2=0.11, P=0.0001); lipo-lymphedema had worse function than stages 1-2.",
      "from_claims": [
        "SCR-LIP-000330"
      ]
    },
    {
      "ref": "DOI:10.1111/ijd.70227",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "note": "The review characterizes lipedema as progressive with impaired mobility and quality of life impact, supporting functional disability; it distinguishes lipedema from lymphedema but does not quantify progression to lymphedema, relying on obse",
      "title": "Lipedema Diagnosis, Clinical Manifestations, and Therapeutics: A Systematic Review",
      "authors": "Vazirnia et al.",
      "journal": "International Journal of Dermatology",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The abstract describes lipedema as a 'chronic,' 'progressive condition' associated with 'impaired mobility' and implicitly with lymphedema overlap (noting misdiagnosis as lymphedema). The statement's additional specifics (Stage IV, dorsal f",
        "date": "2026-06-10"
      },
      "quote": "Lipedema is a distinct, progressive condition requiring early recognition and intervention.",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Systematic review describes lipedema as a distinct, progressive condition with impaired mobility and quality of life, requiring early recognition and intervention.",
      "from_claims": [
        "SCR-LIP-000129"
      ]
    },
    {
      "ref": "DOI:10.1089/lrb.2024.0117",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2025,
      "amato_authored": false,
      "note": "Cross-sectional study directly measuring depression (PHQ-9), life satisfaction (LSI), and QoL (LYMQOL-Leg) in lipedema patients with validated instruments, reporting that lipedema is associated with moderate depression and reduced QoL, bear [grade capped moderate->low per curated Oxford N4]",
      "title": "The Comparative Evaluation of Depression, Life Satisfaction, and Quality of Life Between Female Patients with Lipedema and Lymphedema",
      "authors": "Yaman et al.",
      "journal": "Lymphatic Research and Biology",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "All specific figures (n=37/36, PHQ-9 10.4, LYMQOL 5.47, r=-0.415 correlations) match the source exactly. The statement accurately reflects that lipedema patients show moderate depression and impaired QoL comparable to lymphedema, while lymp",
        "date": "2026-06-10"
      },
      "quote": "Funcionalidade (LEFS): SIGNIFICATIVAMENTE PIOR no linfedema — 0,4455 vs 0,6250 (p = 0,001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In 37 lipedema vs 36 lymphedema women, functional status (LEFS) was significantly worse in lymphedema (0.4455 vs 0.6250, p=0.001); in lipedema BMI correlated with functional impairment.",
      "from_claims": [
        "SCR-LIP-000175"
      ]
    },
    {
      "ref": "DOI:10.3390/ijerph20031989",
      "stance": "refines",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2023,
      "amato_authored": false,
      "note": "The scoping review documents that functional impacts (pain, fatigue, lymphatic system involvement) are reported in the lipedema literature, providing contextual evidence on disability dimensions, but it does not directly establish progressi",
      "title": "Functioning of People with Lipoedema According to All Domains of the International Classification of Functioning, Disability and Health: A Scoping Review",
      "authors": "Kloosterman et al.",
      "journal": "International Journal of Environmental Research and Public Health",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "All specific figures in the statement (53 studies, b435 at 34%, fatigue ~75%, activities and participation at 17%, d450/d850 examples, 50/53 rated weak) are directly supported by the article abstract. The statement accurately characterizes ",
        "date": "2026-06-10"
      },
      "quote": "Domínio 'activities and participation' contemplado em apenas 17% (9/53)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "context",
      "finding": "Scoping review of 53 studies: activities and participation (walking, employment) assessed in only 17%; fatigue in ~75% of patients; 50/53 studies methodologically weak.",
      "from_claims": [
        "SCR-LIP-000339"
      ]
    },
    {
      "ref": "DOI:10.1089/lrb.2021.0039",
      "stance": "context",
      "study_design": "case_series",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2021,
      "amato_authored": false,
      "note": "Small (n=5) uncontrolled proof-of-principle therapy study; it enrolled patients with lipedema plus early lymphedema and addressed functional mobility, providing contextual evidence that lipedema can coexist with lymphedema and impair functi",
      "title": "Physical Therapy in Women with Early Stage Lipedema: Potential Impact of Multimodal Manual Therapy, Compression, Exercise, and Education Interventions",
      "authors": "Donahue et al.",
      "journal": "Lymphatic Research and Biology",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article confirms n=5 women with Stage 1-2 lipedema and early Stage 0-1 lymphedema, VAS reduction from 4.6±1.8 to 0.0±0.0, and PSFS improvement from 4.5±0.5 to 8.3±1.0, all matching the statement. The enrollment criteria do indicate coex",
        "date": "2026-06-10"
      },
      "quote": "Participants with Stage 1-2 lipedema and early Stage 0-1 lymphedema (n = 5, age = 38.4 ± 13.4 years, body mass index = 27.2 ± 4.3 kg/m2) underwent nine visits of physical therapy in 6 weeks for management of symptoms impacting functional mobility and QoL.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "context",
      "finding": "In 5 women with early lipedema and early lymphedema, multimodal physical therapy reduced pain (VAS 4.6 to 0.0) and improved function (PSFS 4.5 to 8.3).",
      "from_claims": [
        "SCR-LIP-000336"
      ]
    },
    {
      "ref": "DOI:10.1097/psn.0000000000000245",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2018,
      "amato_authored": false,
      "note": "This is a narrative/educational review article summarizing existing literature on lipedema. It directly addresses progression to lymphedema (lipolymphedema, Stage IV) and functional disability (immobility, decreased quality of life), suppor",
      "title": "Lipedema: A Commonly Misdiagnosed Fat Disorder",
      "authors": "Caruana",
      "journal": "Plastic Surgical Nursing",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly states lipedema is progressive and can lead to immobility and significant decrease in quality of life, and describes Stage IV as lipolymphedema with dorsal foot edema and positive Stemmer sign — all consistent with th",
        "date": "2026-06-10"
      },
      "quote": "Early diagnosis and treatment are crucial, as the disease is progressive and can lead to immobility as well as a significant decrease in the qualit",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Narrative review describes lipedema as progressive, advancing to lipolymphedema and potentially leading to immobility; no functional data.",
      "from_claims": [
        "SCR-LIP-000129"
      ]
    },
    {
      "ref": "DOI:10.1002/oby.22597",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2019,
      "amato_authored": false,
      "note": "Narrative/systematic review describing lipedema staging where stage IV is lipolymphedema (positive Stemmer), consistent with progression to lymphedema and deforming morphology affecting function, but it does not present quantitative data on",
      "title": "Lipedema: A Call to Action!",
      "authors": "Buso et al.",
      "journal": "Obesity",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly describes Stage IV as 'lipolinfedema com Stemmer positivo' and characterizes lipedema as a chronic progressive disease leading to disability and daily functioning impairment, consistent with the statement. The staging",
        "date": "2026-06-10"
      },
      "quote": "4 estágios (I: pele lisa, hipodermis aumentada; II: nódulos palpáveis peau d'orange; III: pregas/reentrâncias com massas deformantes; IV: lipolinfedema com Stemmer positivo)",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Review describes four stages, from enlarged hypodermis to deforming masses and lipolymphedema with positive Stemmer sign, without quantitative functional data.",
      "from_claims": [
        "SCR-LIP-000129"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000330",
    "SCR-LIP-000129",
    "SCR-LIP-000175",
    "SCR-LIP-000339",
    "SCR-LIP-000336"
  ],
  "questions_consolidated": [
    "SQ-LIP-000017",
    "SQ-LIP-000039",
    "SQ-LIP-000040"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00211",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000017"
    }
  ],
  "statement_pt": "O comprometimento funcional no lipedema parece piorar com o avanço do estágio e com o lipolinfedema, embora os dados quantitativos sejam limitados.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000017",
      "role": "supporting",
      "question": "Does lipedema progress to lymphedema and cause functional disability?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000017.html"
    },
    {
      "id": "SQ-LIP-000039",
      "role": "refines",
      "question": "Does lipedema progress to lymphedema (lipo-lymphedema)?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000039.html"
    },
    {
      "id": "SQ-LIP-000040",
      "role": "supporting",
      "question": "Does lipedema cause functional disability and mobility limitation?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000040.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000677.html"
}